Download Cell-Based Bioassays E-Book

Jarlath Keating Joins as President of Solvias Group USA

Press Release: Solvias Expands U.S. Capabilities as RTP Center Becomes cGMP-Ready

Article: CSO Danny Galbraith, PhD shares his insights with Drug Target Review.

Webinar: Antibody Drug Conjugates Overcoming Analytical Challenges in Next Gen Cancer Therapies 22

Solvias Earns Strong First Assessment from EcoVadis

One partner for your entire
drug development journey
Let’s advance your development project
175
+
PhD-level scientists
800
+
team members in Europe & U.S.
700
+
customers worldwide
19
of the top 20 pharma companies choose Solvias